Cargando…
Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration
SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is a subtype of invasive breast cancer with an aggressive phenotype that has decreased survival compared with other types of breast cancers, due in part to the lack of biomarker driven targeted therapies. Here, we show that breast cancer patients...
Autores principales: | Chen, Xian, Yang, Dong, Carey, Jason P. W., Karakas, Cansu, Albarracin, Constance, Sahin, Aysegul A., Arun, Banu K., Guray Durak, Merih, Li, Mi, Kohansal, Mehrnoosh, Bui, Tuyen N., Ha, Min-Jin, Hunt, Kelly K., Keyomarsi, Khandan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036262/ https://www.ncbi.nlm.nih.gov/pubmed/33916118 http://dx.doi.org/10.3390/cancers13071656 |
Ejemplares similares
-
PKC iota promotes ovarian tumor progression through deregulation of cyclin E
por: Nanos-Webb, Angela, et al.
Publicado: (2015) -
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
por: Caruso, Joseph A, et al.
Publicado: (2014) -
Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
por: Caruso, Joseph A, et al.
Publicado: (2015) -
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers
por: Lulla, Amriti R., et al.
Publicado: (2021) -
Low-molecular-weight cyclin E: the missing link between biology and clinical outcome
por: Akli, Said, et al.
Publicado: (2004)